共 147 条
- [61] Furtado R.R., Soares D.C., Prado A.F., Farias L.H.S., da Silva B.J.M., Rodrigues A.P.D., Silva E.O., Constitutive nitric oxide synthase-like enzyme in two species involved in cutaneous and mucocutaneous leishmaniasis, Parasitol Int, 83, (2021)
- [62] Glennie N.D., Volk S.W., Scott P., Skin-resident CD4+ T cells protect against Leishmania major by recruiting and activating inflammatory monocytes, PLoS Pathog, 13, (2017)
- [63] Gobert G.N., Chai M., McManus D.P., Biology of the Schistosome lung-stage schistosomulum, Parasitology, 134, pp. 453-460, (2007)
- [64] Graczyk T.K., Fried B., Human waterborne trematode and protozoan infections, Adv Parasitol, 64, pp. 111-160, (2007)
- [65] Gradoni L., Ascenzi P., Nitric oxide and anti-protozoan chemotherapy, Parassitologia, 46, pp. 101-103, (2004)
- [66] Gramaglia I., Sobolewski P., Meays D., Contreras R., Nolan J.P., Frangos J.A., Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria, Nat Med, 12, pp. 1417-1422, (2006)
- [67] Green S.J., Meltzer M.S., Hibbs J.B., Nacy C.A., Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism, J Immunol, 144, pp. 278-283, (1990)
- [68] Guedes P.M., Oliveira F.S., Gutierrez F.R., da Silva G.K., Rodrigues G.J., Bendhack L.M., Franco D.W., Do Valle Matta M.A., Zamboni D.S., da Silva R.S., Silva J.S., Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease, Br J Pharmacol, 160, pp. 270-282, (2010)
- [69] Guillermo L.V., DaMatta R.A., Nitric Oxide Inhibition after Toxoplasma gondii infection of chicken macrophage cell lines, Poult Sci, 83, pp. 776-782, (2004)
- [70] Gupta S., Bhatia V., Wen J.J., Wu Y., Huang M.H., Garg N.J., Trypanosoma cruzi infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes, Free Radic Biol Med, 47, pp. 1414-1421, (2009)